Jane Street Group, LLC Sarepta Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$124.33 - $156.75 $9.18 Million - $11.6 Million	73,800 New	73,800 $9.22 Million
Q1 2022 May 17, 2022	SELL	$63.15 - $90.42 $290,490 - $415,932	-4,600 Reduced 3.11%	143,400 $11.2 Million
Q4 2021 Feb 15, 2022	BUY	$77.28 - $99.42 $6.14 Million - $7.89 Million	79,400 Added 115.74%	148,000 $13.3 Million
Q3 2021 Nov 16, 2021	SELL	$65.97 - $92.48 $2.15 Million - $3.01 Million	-32,600 Reduced 32.21%	68,600 $6.34 Million
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $4.43 Million - $5.53 Million	-63,800 Reduced 38.67%	101,200 $7.87 Million
Q1 2021 May 18, 2021	SELL	$72.25 - $168.95 $10.4 Million - $24.2 Million	-143,400 Reduced 46.5%	165,000 $12.3 Million
Q4 2020 Feb 17, 2021	BUY	$125.56 - $178.74 $8.14 Million - $11.6 Million	64,800 Added 26.6%	308,400 $52.6 Million
Q3 2020 Nov 17, 2020	BUY	$127.12 - $172.34 $2.15 Million - $2.91 Million	16,900 Added 7.45%	243,600 $34.2 Million
Q2 2020 Aug 17, 2020	BUY	$93.0 - $171.7 $18.4 Million - $34 Million	198,000 Added 689.9%	226,700 $36.3 Million
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $10.2 Million - $16.2 Million	-123,400 Reduced 81.13%	28,700 $2.81 Million
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $7.62 Million - $13.5 Million	99,600 Added 189.71%	152,100 $19.6 Million
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $1.76 Million - $3.8 Million	24,200 Added 85.51%	52,500 $3.95 Million
Q2 2019 Aug 15, 2019	SELL	$112.21 - $151.95 $6.59 Million - $8.92 Million	-58,700 Reduced 67.47%	28,300 $4.3 Million
Q1 2019 May 16, 2019	BUY	$106.67 - $151.68 $7.17 Million - $10.2 Million	67,200 Added 339.39%	87,000 $10.4 Million
Q4 2018 Feb 15, 2019	BUY	$97.32 - $148.76 $671,508 - $1.03 Million	6,900 Added 53.49%	19,800 $2.16 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $357,461 - $500,681	3,100 Added 31.63%	12,900 $2.08 Million
Q2 2018 Aug 15, 2018	SELL	$71.74 - $153.69 $373,048 - $799,188	-5,200 Reduced 34.67%	9,800 $1.3 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $2.34 Million - $3.57 Million	-43,400 Reduced 74.32%	15,000 $1.11 Million
Q4 2017 Feb 15, 2018	SELL	$47.64 - $56.75 $262,020 - $312,125	-5,500 Reduced 8.61%	58,400 $3.25 Million
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $2.28 Million - $3.01 Million	63,900	63,900 $2.9 Million

Others Institutions Holding SRPT

# of Institutions

530

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.31 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.14 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$793 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$552 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$541 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account